Loading...
Loading...
, Jim Cramer said that
Horizon Pharma PLCHZNP can continue to go higher. He explained that the company grows by acquisition and the stock struggled recently because its last big acquisition has been turned down. It has also been linked to
Valeant Pharmaceuticals Intl IncVRX, which is now out of the woods, added Cramer.
Cramer is cautious about
Ambarella IncAMBA and the semiconductor space. In the sector he likes the simple ones, like
Intel CorporationINTC and
Lam Research CorporationLRCX.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in